CTRI/2013/09/004023尚未招募未知
Prevalence of KRAS and BRAF mutations in subjects diagnosed with Colorectal Cancer- a prospective, single center study
Dr Prachi S Patil0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Subjects with age above 18 years
- •Subjects with histologically confirmed adenocarcinoma of the colon or rectum
- •Subjects who have not received any prior systemic therapy for CRC
排除标准
- •Subjects with previous systemic therapy for CRC
研究者
相似试验
已完成
不适用
Effects of mutations in KRAS and BRAF gene and histological parameters on the clinical course of disease in patients with metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of colonCancerISRCTN10604174Institute of Oncology Ljubljana (Slovenia)400
已完成
不适用
A clinical study of relevance to KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerColorectal cancerJPRN-UMIN000013154Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences20
招募中
不适用
Comparative analysis of KRAS and EGFR mutation detection in liquid biopsy vs tissue biopsy in patients with NSCLCNon-small-cell lung carcinoma10038666lung cancerNL-OMON48625Jeroen Bosch Ziekenhuis150
招募中
不适用
Clinical relevance of KRAS and GNAS Mutationen in cell-free DNA and circulating epithelial cells regarding the development of pancreatic cancer in IPMN patientsD13.6PancreasDRKS00023356niversitätsklinikum Hamburg-Eppendorf100
已完成
不适用
Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine PatientsColorectal NeoplasmsNCT01082757Merck KGaA, Darmstadt, Germany1,524